Daclizumab and blood creatinine increased Patient Reports February 12, 2012
Daclizumab Side Effects Report #4597506-1
Daclizumab side effect was reported by a Physician from on Feb 23, 2005. Female patient, 66 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, dehydration, diarrhoea, fluid overload, ventricular hypertrophy. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, PROGRAF, STEROIDS NOS. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #4894440-4
Daclizumab side effect was reported by a Physician from ISRAEL on Jan 17, 2006. Female patient, 65 years of age, weighting 158.7 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, enterococcal infection, epididymitis, klebsiella infection, necrosis, neurogenic bladder, orchitis, phimosis, pneumonia klebsiella. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, CYCLOSPORINE, OMEPRAZOLE, PREDNISONE, NORMITEN, GANCICLOVIR, SIMVASTATIN. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #4698307-6
Daclizumab side effect was reported by a Physician from on May 26, 2004. Female patient, 64 years of age, weighting 134.5 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, kidney transplant rejection, urinary tract infection
, urosepsis. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, SIROLIMUS. Patient was hospitalized. Patient recovered.Daclizumab Side Effects Report #4584096-2
Daclizumab side effect was reported by a Physician from on Jan 09, 2004. Female patient, 63 years of age, weighting 127.2 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, herpes virus infection. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, CACO, BACTRIM DS, ZOVIRAX. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #4617084-8
Daclizumab side effect was reported by a Physician from on Jan 09, 2004. Female patient, 63 years of age, weighting 127.2 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, gastric infection, herpes virus infection, pharyngitis. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, CACO, BACTRIM, ZOVIRAX. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #4766469-8
Daclizumab side effect was reported by a Physician from POLAND on May 05, 2003. Male patient, 59 years of age, weighting 137.6 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, herpes zoster, hypertension, parathyroid tumour benign, peptic ulcer
, refusal of treatment by patient, vocal cord paralysis. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, NEORAL, PREDNISONE, ISOSORBIDE MONONITRATE, NITRENDIPINE, PRAZOSINE, DIHYDRALAZINE. Patient was hospitalized. Patient recovered.Daclizumab Side Effects Report #4611480-0
Daclizumab side effect was reported by a Physician from on July 26, 2002. Male patient, 53 years of age, weighting 164.5 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, nephritis, squamous cell carcinoma. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, PROGRAF, PREDNISOLONE, TRIOBE, FAMOTIDIN, AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #4629944-2
Daclizumab side effect was reported by a Physician from on July 26, 2002. Male patient, 53 years of age, weighting 164.5 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, nephritis, squamous cell carcinoma. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, PROGRAF, PREDNISOLONE, TRIOBE, FAMOTIDIN, AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #4630018-5
Daclizumab side effect was reported by a Physician from on July 26, 2002. Male patient, 53 years of age, weighting 164.5 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, nephritis, squamous cell carcinoma. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, PROGRAF, PREDNISOLONE, TRIOBE, FAMOTIDIN, AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #4654761-7
Daclizumab side effect was reported by a Physician from on Oct 23, 2003. Male patient, 53 years of age, weighting 113.5 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: anaemia, bacterial infection
, blood creatinine increased, bradycardia, dehydration, hyperglycaemia, nephropathy, oliguria, pneumonia
. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, TACROLIMUS, PREDNISONE, CILAZAPRIL, RESPRIM. Patient was hospitalized. Patient died on 08/23/2004.Daclizumab Side Effects Report #5511250-5
Daclizumab side effect was reported by a Physician from GERMANY on Oct 31, 2007. Male patient, 34 years of age, weighting 160.9 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, diarrhoea, renal artery stenosis. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, CYCLOSPORINE. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #4570323-4
Daclizumab side effect was reported by a Physician from on Dec 18, 2003. Male patient, 34 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, hypertension, kidney transplant rejection, renal artery stenosis. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, CYCLOSPORINE, METHYLPREDNISOLONE, TACROLIMUS. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #4638993-X
Daclizumab side effect was reported by a Physician from on Dec 18, 2003. Male patient, 34 years of age, weighting 160.9 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, diarrhoea, hypertension, kidney transplant rejection, renal artery stenosis. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, CYCLOSPORINE. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #4629948-X
Daclizumab side effect was reported by a Physician from on Aug 02, 2004. Female patient, 31 years of age, weighting 132.5 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, complications of transplanted kidney, cytomegalovirus infection
, human polyomavirus infection, polyomavirus interstitial nephritis, transplant rejection. Daclizumab dosage: DOSE = 125 MG.. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, PREDNISONE, COTRIMOXAZOL. Patient was hospitalized. Patient recovered.Daclizumab Side Effects Report #4608690-5
Daclizumab side effect was reported by a Physician from on Jan 18, 2005. Female patient, child 3 years of age, weighting 45.19 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, fluid overload, oliguria, upper respiratory tract infection, viral upper respiratory tract infection. Daclizumab dosage: 40 MG GIVEN ON 06 JANUARY 2005.. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, PROGRAF, MANNITOL, DOPAMINE. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #4630701-1
Daclizumab side effect was reported by a Physician from on Jan 18, 2005. Female patient, child 3 years of age, weighting 45.19 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: atherosclerosis, blood creatinine increased, fluid overload, graft complication, kidney transplant rejection, oliguria, renal cyst, upper respiratory tract infection. Daclizumab dosage: 40 MG GIVEN ON 06 JANUARY 2005.. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, PROGRAF, MANNITOL, DOPAMINE. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #4698304-0
Daclizumab side effect was reported by a Physician from on Jan 18, 2005. Female patient, child 3 years of age, weighting 46.52 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: atherosclerosis, blood creatinine increased, complications of transplanted kidney, fluid overload, oliguria, renal cyst, tenderness, upper respiratory tract infection, viral upper respiratory tract infection. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, PROGRAF, MANNITOL, DOPAMINE, MORPHINE. Patient was hospitalized. Patient recovered.
Daclizumab Side Effects Report #4637905-2
Daclizumab side effect was reported by a Physician from on Jan 18, 2005. Female patient, child 2 years of age, weighting 36.16 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: atelectasis, bacterial infection
, bacterial test positive, blood creatinine increased, catheter related infection, cytomegalovirus infection
, dehydration, electrolyte imbalance, enterococcal infection. Daclizumab dosage: unknown. During the same period patient was treated with TACROLIMUS, PREDNISONE, PREDNISOLONE, AZATHIOPRINE, SIROLIMUS. Patient was hospitalized. Patient recovered.Daclizumab Side Effects Report #4700457-2
Daclizumab side effect was reported by a Physician from on June 16, 2005. Male patient, child 11 years of age, weighting 91.05 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, blood creatinine increased, cellulitis
, dehydration, disease recurrence, dysuria, epstein-barr virus infection, fatigue, fluid intake reduced. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, AZATHIOPRINE. Patient was hospitalized. Patient recovered.
Daclizumab and blood creatinine increased 